Schonfeld Strategic Advisors LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,312,741
+8.8%
201,634
+140.0%
0.02%0.0%
Q2 2023$2,126,040
+20.0%
84,000
+52.7%
0.02%
+5.9%
Q1 2023$1,771,582
-44.0%
55,001
-67.9%
0.02%
-34.6%
Q4 2022$3,163,139
-46.0%
171,351
-21.0%
0.03%
-46.9%
Q3 2022$5,857,000
+1899.0%
216,899
+2090.9%
0.05%
+1533.3%
Q2 2021$293,000
-88.6%
9,900
-88.2%
0.00%
-98.4%
Q1 2018$2,578,000
-24.4%
83,700
-12.2%
0.19%
-30.8%
Q4 2017$3,409,00095,3570.28%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders